tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks Steps Up Investor Outreach with September Conference Lineup
Company AnnouncementsZymeworks Steps Up Investor Outreach with September Conference Lineup
2d ago
ZYME
Zymeworks price target raised to $44 from $40 at B. Riley
PremiumThe Fly
Zymeworks price target raised to $44 from $40 at B. Riley
3d ago
ZYME
Citi adds ‘upside 90-day catalyst watch’ on Zymeworks in FDA decision
PremiumThe Fly
Citi adds ‘upside 90-day catalyst watch’ on Zymeworks in FDA decision
3d ago
ZYME
Zymeworks price target raised to $32 from $31 at Truist
PremiumThe Fly
Zymeworks price target raised to $32 from $31 at Truist
6d ago
ZYME
Zymeworks price target lowered to $46 from $47 at Stifel
PremiumThe Fly
Zymeworks price target lowered to $46 from $47 at Stifel
6d ago
ZYME
Zymeworks price target raised to $40 from $37 at Wells Fargo
PremiumThe FlyZymeworks price target raised to $40 from $37 at Wells Fargo
6d ago
ZYME
Zymeworks reports Q2 EPS (62c), consensus (55c)
Premium
The Fly
Zymeworks reports Q2 EPS (62c), consensus (55c)
7d ago
ZYME
Zymeworks Posts Strong Q2 Results, Highlights Growth Catalysts
Premium
Company Announcements
Zymeworks Posts Strong Q2 Results, Highlights Growth Catalysts
7d ago
8K
ZYME
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
8d ago
JNJ
JAZZ
Zymeworks management to meet with B. Riley
PremiumThe Fly
Zymeworks management to meet with B. Riley
23d ago
ZYME
Zymeworks price target raised to $31 from $28 at Truist
PremiumThe Fly
Zymeworks price target raised to $31 from $28 at Truist
1M ago
ZYME
Zymeworks price target raised to $37 from $34 at Wells Fargo
PremiumThe Fly
Zymeworks price target raised to $37 from $34 at Wells Fargo
1M ago
ZYME
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
PremiumRatingsZymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
1M ago
ZYME
Zymeworks price target raised to $37 from $35 at Citi
Premium
The Fly
Zymeworks price target raised to $37 from $35 at Citi
1M ago
TBPH
ZYME
Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
Premium
Ratings
Zymeworks’ TBPH Acquisition Seen as Cash-Flow Accretive, Supports Buy Rating and Unchanged $34 Price Target
1M ago
ZYME
Morning Movers: Comcast surges after announcing spinoff of NBCUniversal
PremiumThe Fly
Morning Movers: Comcast surges after announcing spinoff of NBCUniversal
1M ago
VZ
BTI
Zymeworks to Acquire Theravance in Strategic Merger
PremiumCompany Announcements
Zymeworks to Acquire Theravance in Strategic Merger
1M ago
8K
ZYME
M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
PremiumMarket News
M&A News: Biotech Group Zymeworks Buys Lung Disease-Fighting Peer Theravance for $1B
2M ago
TBPH
ZYME
Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash
PremiumThe Fly
Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash
2M ago
TBPH
ZYME
Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M
PremiumThe FlyZymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M
2M ago
TBPH
ZYME
Zymeworks to acquire Theravance Biopharma for $17.00 per share
Premium
The Fly
Zymeworks to acquire Theravance Biopharma for $17.00 per share
2M ago
TBPH
ZYME
Zymeworks Rated Buy on Undervalued Royalty Streams and High-Optionality Pipeline, Says Analyst
Premium
Ratings
Zymeworks Rated Buy on Undervalued Royalty Streams and High-Optionality Pipeline, Says Analyst
2M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >